Edcardo Odom

Edcardo Odom is an accomplished professional with extensive experience in market access strategy within the pharmaceutical industry. Currently serving as Director of US Value and Access at Amgen since 2020, Edcardo Odom focuses on developing strategic market access plans for the rare disease treatment KRYSTEXXA. Previously, Odom held the position of Associate Director for Market Access Strategy at CSL from 2016 to 2019, where strategic direction was set for rare disease products. Edcardo Odom also contributed significantly as Senior Manager of Market Access at Sanofi Genzyme, establishing successful access strategies for the MS franchise. Additional experience includes a role as Territory Representative at Actavis and as Vice President of Business Development at NaviSync LLC, where strategic objectives for pharmaceutical clients were developed and implemented. Edcardo Odom holds a Bachelor of Business Administration from the University of Mississippi.